CrossrefInfokarte
Eomesodermin in renal cell carcinoma: Epigenetic and immune crosstalk driving tumor progression (Review)
International Journal of Oncology · 2026-09-18 · 69 (5) · 1-14
DOI: 10.3892/ijo.2026.5941 ↗Abstract
Kein Abstract verfügbar.
EUVIMED